Eurofins Scientific SE - Company Profile
Powered by 
All the data and insights you need on Eurofins Scientific SE in one report.
$295
- Save hours of research time and resources with
our up-to-date Eurofins Scientific SE Strategy Report
- Understand Eurofins Scientific SE position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Eurofins Scientific SE (Eurofins) is a life sciences company, which provides analytical testing services to clients in various industries. The company offers food and feed testing, biopharma services, pharma discovery services, pharma early development, pharma central laboratory, biopharma product testing, product testing, agroscience services, forensic services and environmental testing. Its analytical methods help in evaluating the safety, identity, composition, origin, authenticity and purity of biological products and substances. It harnesses its expertise in logistics and information technology to deliver a range of services. The company operates across Europe, North America, Asia Pacific, the Middle East and South America. Eurofins is headquartered in Luxembourg.
Headquarters
Luxembourg
Address
23 Val Fleuri, Luxembourg, 1526
Website
www.eurofins.com
No of Employees
62,000
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
ERF (EPA)
Revenue (2022)
$7.1B
-0.1%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-22.1%
(2022 vs 2021)
Market Cap*
$11.4B
Net Profit Margin (2022)
XYZ
-22.0%
(2022 vs 2021)
* As of and is in US$
Eurofins Scientific SE premium industry data and analytics
Products and Services
| Services |
|---|
| Food and Feed Testing |
| Environment Testing |
| Pharma Services |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In December, the company and Thermo Fisher Scientific signed a virtual power purchase agreement with ib vogt for a capacity of 91 MW and 36 MW and to provide 100% renewable energy to over half of Thermo Fisher’s continental European sites. |
| 2023 | Acquisitions/Mergers/Takeovers | In November, the company announced the acquisition of Labor 3. |
| 2023 | Acquisitions/Mergers/Takeovers | In November, the company announced the acquisition of Quasfar. |
Competitor Comparison
| Key Parameters | Eurofins Scientific SE | SGS SA | Bureau Veritas SA | Intertek Group Plc | bioMerieux SA |
|---|---|---|---|---|---|
| Headquarters | Luxembourg | Switzerland | France | United Kingdom | France |
| City | Luxembourg | Geneve | Neuilly-Sur-Seine | London | Craponne |
| State/Province | - | - | Haute Normandie | England | Rhone Alpes |
| No. of Employees | 62,000 | 97,797 | 82,589 | 43,597 | 13,842 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Gilles G. Martin | Chief Executive Officer; Chairman | Executive Board | - | 60 |
| Christian Wurst | Chief Operating Officer - Food & Environment Testing | Senior Management | 2019 | - |
| Sandra Hoeylaerts | Chief Human Resources Officer | Senior Management | 2021 | - |
| Gabriel Julia | Senior Vice President - Clinical Diagnostics - Europe | Senior Management | - | - |
| Beth DiPaolo | Senior Vice President - Professional Scientific Services North America | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward